Shia LaBeouf ‘leaving all public life’ after plagiarism scandal

Shia LaBeouf ‘leaving all public life’ after plagiarism scandal

HE'S DONE: Shia LaBeouf says he's leaving the limelight. Photo: Associated Press

Shia LaBeouf has revealed plans to retire following accusations he plagiarized a graphic novel in a short film he directed.

“The Transformers” star became embroiled in controversy following accusations that he based his movie, “Howard Cantour,” on a book called “Justin M. Damiano” by Daniel Clowes.

Following the allegations, the actor offered a series of public apologies to the author through and even hired a skywriting plane in Los Angeles to spell out his regret.

But the apologies did not succeed in appeasing Clowes’ lawyers, who have since threatened the actor with legal action.

Now, in the latest twist in the saga, LaBeouf took to on Friday to claim his “artistic integrity” has been attacked and as a result he has decided to turn his back on his career.

In a series of posts, LaBeouf writes of his impending retirement and thanks his fans


in Entertainment

MOVIES: 31 days of Halloween

Shelley Duvall hides from Jack Nicholson in 'The Shining.'

Get into the Halloween spirit by watching one of these scary movies.

in National

General Mills recalls 1.8 million boxes of Cheerios


The company is recalling the original and honey nut flavored varieties.

in Entertainment, Sports

DraftKings, FanDuel defend integrity after insider bet


The two major U.S. sports fantasy companies are defending their businesses' integrity after an employee used insider information to place bets in the unregulated multi-billion-dollar industry.

in Entertainment

Price hike puts popular U.S. Disneyland annual pass over $1,000


It's going to cost a pretty penny to see the Happiest Place on Earth.

in National, World

Obama confident Congress will approve Trans-Pacific Partnership


The U.S. is one of 12 Pacific Rim nations to reach a pact this week that would liberalize commerce, affecting the costs of products ranging from dairy to biotech drugs.